Research Peptides
A high-purity research peptide studied in growth-hormone and appetite research. Available in 10mg, with every batch independently tested and dispatched from the UK.
A high-purity research peptide studied in growth-hormone and appetite research. Available in 10mg, with every batch independently tested and dispatched from the UK.
GHRP-6 peptide UK is Crown Peptides' synthetic hexapeptide growth-hormone secretagogue, available in 10mg strength for laboratory research.
Supplied for laboratory research purposes only — not for human consumption or for medical, veterinary or diagnostic use.
GHRP-6 is a synthetic six-amino-acid peptide and one of the classic growth-hormone-releasing peptides. Its research activity is associated primarily with the growth-hormone secretagogue receptor, also known as the ghrelin receptor or GHSR.
GHRP-6 is studied in endocrine and receptor-pharmacology models involving GHSR activation, pituitary growth-hormone release and appetite-associated signalling. It is historically important in growth-hormone secretagogue research because it helped demonstrate that ghrelin-receptor pathways can regulate pituitary signalling independently of the GHRH receptor (Learn more), alongside related secretagogue peptides such as [Ipamorelin] and [CJC-1295 with DAC].
Compound-level reference data. Batch-specific results appear on the Certificate of Analysis.
Work out concentration with the peptide calculatorCrown Peptides GHRP-6 is supplied for controlled laboratory research with batch-specific analytical documentation. High-Performance Liquid Chromatography (HPLC) can assess chromatographic purity, while Mass Spectrometry provides molecular information used to support identity verification.
The batch-specific Certificate of Analysis is the definitive source for the exact purity result, identity data and analytical specification of the material supplied.
Researchers working with GHRP-6 may also be interested in [Ipamorelin], [CJC-1295 with DAC], [CJC-1295 + Ipamorelin], [Sermorelin] and [Tesamorelin] — other growth-hormone-releasing peptides studied in the same endocrine research pathway.
GHRP-6 is a synthetic hexapeptide growth-hormone secretagogue studied through the ghrelin/GHSR receptor system, supplied by Crown Peptides at 10mg strength.
Its primary research target is the growth-hormone secretagogue receptor, commonly called GHSR or the ghrelin receptor.
Research includes receptor pharmacology, pituitary growth-hormone release, endocrine signalling and appetite-associated pathways.
GHRP-6 acts mainly through the ghrelin/GHSR pathway, whereas GHRH analogues such as [CJC-1295 with DAC] act through the GHRH receptor.
Peptide purity and identity can be evaluated using HPLC and Mass Spectrometry, with the exact batch results shown on the CoA.
Every batch is published openly — identity, purity and batch number, with no account needed.
Supplied for laboratory research purposes only — not for human consumption or for medical, veterinary or diagnostic use.
Each batch undergoes internal analytical verification using chromatographic and spectrometric methods prior to lyophilisation.
• HPLC Analysis
• Mass Spectrometry Confirmation
• Batch Traceability
By purchasing this product you confirm that you are a qualified researcher and that this compound will be used exclusively for laboratory research purposes.
This product is not intended for diagnostic or therapeutic use.
Any human or medical use is strictly prohibited.
Store in a cool, dry, secure and sterile environment away from any unauthorised persons or children.
Disclaimer: All products are sold strictly for laboratory research purposes only. Not for human or veterinary use, consumption, therapeutic, or diagnostic application. By purchasing, you confirm you are a qualified professional and legally permitted to handle these materials in compliance with all applicable laws and regulations. Misuse, resale for unauthorised purposes, or unlawful application is strictly prohibited. Crown Peptides UK disclaims all liability for improper use, handling, or regulatory non-compliance.